Evidence map›Paper›PMID 33386580›Full record

ArticleMolecular biotechnology2021

Necessity for Validation of Effectiveness of Selected Guide RNA In Silico for Application of CRISPR/Cas9.

Dong-Hwan Kim, Joonbum Lee, Yeunsu Suh, Kichoon Lee

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. In Vivo Rapid Investigation of CRISPR-Based Base Editing Components inInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dong-Hwan KimDepartment of Animal Sciences, The Ohio State University, Columbus, OH, 43210, USA.
Joonbum LeeDepartment of Animal Sciences, The Ohio State University, Columbus, OH, 43210, USA.
Yeunsu SuhDepartment of Animal Sciences, The Ohio State University, Columbus, OH, 43210, USA.
Kichoon LeeDepartment of Animal Sciences, The Ohio State University, Columbus, OH, 43210, USA. lee.2626@osu.edu.ORCID http://orcid.org/0000-0001-6169-7516
The Ohio State University · US

Funding

National Institute of Food and Agriculture 2020-67015-31537
6 · The paper itself

Abstract

Selection of guide RNA (gRNA) is important to increase the efficiency of gene editing in the CRISPR/Cas9 system. Due to the variation in actual efficiency of insertion/deletion (indel) mutation among selected gRNAs in silico, reliable methods for validation of efficiency of gRNA need to be developed. Three gRNAs with high on-target scores (72.0 for target 1, 65.4 for target 2, and 62.9 for target 3) were designed to target the quail retinol binding protein 7 (qRbp7) gene, and indel efficiencies were predicted by the Sanger sequencing and Inference of CRISPR Edits (ICE) analysis of sorted cell populations receiving the CRISPR/Cas9 vector. Unlike the order of on-target scores among 3 gRNAs, predicted rates of indel mutations were highest in gRNA2, intermediate in gRNA1, and lowest in gRNA3. This was confirmed by actual indel mutation rates, 51.8% in gRNA2, 31% in gRNA1, and 12.9% in gRNA3, which were calculated by sequencing individual allele cloned into a vector. These data showed a rapid and reliable method for estimation of the efficiency of selected gRNAs, providing a critical necessary step for successful gene editing for further applications.

Indexed as

Computer SimulationAnimalsBase SequenceCell LineCRISPR-Cas SystemsGenetic VectorsGreen Fluorescent ProteinsINDEL MutationPolymorphism, Single NucleotideQuailRetinol-Binding ProteinsRNA, Guide, CRISPR-Cas SystemsGreen Fluorescent ProteinsRetinol-Binding ProteinsRNA, Guide, CRISPR-Cas SystemsCRISPR/Cas9Gene editingGuide RNAQuail cellsSequencingValidation

Identifiers

PMID33386580
OpenAlexW3114544698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.